NEORX CORP
S-3, EX-23.1, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEORX CORP, S-3, EX-5.1, 2000-08-14
Next: CONSOLIDATED CAPITAL PROPERTIES VI, 10QSB, 2000-08-14



<PAGE>   1

                                                                    Exhibit 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors
NeoRx Corporation:

        We consent to the use of our report incorporated herein by reference and
to the reference to our firm under the heading "Experts" in the prospectus.



                                        /s/ KPMG LLP
                                        ----------------------------------------
                                        KPMG LLP

Seattle, Washington

August 11, 2000



                                      II-6



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission